A patient on a second course of nitrofurantoin (Macrobid) for a urinary tract infection developed fever and chills on day three; the initial urinalysis before trimethoprim‑sulfamethoxazole (Bactrim) was not a clean‑catch specimen, while subsequent urinalyses were clean‑catch but no cultures were obtained. What is the appropriate next step in management?

Management of Fever and Chills During Second Course of Nitrofurantoin for Recurrent UTI

Stop nitrofurantoin immediately and evaluate for acute drug-induced toxicity, particularly pulmonary and systemic hypersensitivity reactions, which can present with fever, chills, and systemic inflammatory response within hours to days of nitrofurantoin exposure. 1, 2

Immediate Assessment and Differential Diagnosis

The development of fever and chills on day three of a second nitrofurantoin course raises three critical possibilities that must be distinguished:

• Acute nitrofurantoin toxicity (pulmonary or systemic hypersensitivity) typically presents with fever, chills, dyspnea, and systemic inflammatory response within hours to days of drug exposure, particularly in patients with prior nitrofurantoin exposure 1, 2
• Treatment failure due to resistant organisms or inadequate source control, suggested by persistent symptoms despite appropriate therapy 3, 4
• Progression to pyelonephritis or complicated infection, indicated by fever >38.3°C, flank pain, or systemic signs 3, 4

Critical Clinical Evaluation

Obtain the following immediately to differentiate these diagnoses:

• Vital signs including temperature, heart rate, respiratory rate, blood pressure, and oxygen saturation to assess for systemic inflammatory response or sepsis 1, 2
• Pulmonary examination for dyspnea, cough, chest pain, rales, or hypoxia—acute nitrofurantoin pulmonary toxicity can present as noncardiogenic pulmonary edema with bilateral infiltrates 5, 2
• Specific urinary symptoms: dysuria, frequency, urgency, suprapubic pain, flank pain, or costovertebral angle tenderness to distinguish lower versus upper tract infection 3, 4
• Timing correlation: symptoms appearing within 24–72 hours of nitrofurantoin initiation strongly suggest drug toxicity rather than treatment failure 1, 2

Diagnostic Workup

Before making any treatment decision, obtain:

• Properly collected urine culture with susceptibility testing from a clean-catch or catheterized specimen to identify resistant organisms and guide targeted therapy 3, 4
• Complete blood count to assess for leukocytosis with eosinophilia (suggests drug hypersensitivity) versus left shift (suggests bacterial infection) 5, 2
• Inflammatory markers including C-reactive protein and procalcitonin, which can be markedly elevated in both nitrofurantoin toxicity and bacterial sepsis 2
• Liver function tests to detect transaminitis, a recognized complication of nitrofurantoin toxicity 1
• Chest radiograph if any respiratory symptoms are present—bilateral lower lobe interstitial infiltrates with pleural effusions suggest nitrofurantoin pulmonary toxicity 5, 2

Immediate Management Algorithm

If Nitrofurantoin Toxicity Is Suspected (Fever/Chills + Respiratory Symptoms or Eosinophilia)

Discontinue nitrofurantoin immediately—this is the single most important intervention, as continued exposure can progress to severe pulmonary edema or systemic inflammatory response syndrome 5, 1, 2

• Supportive care with supplemental oxygen if hypoxic, bronchodilators for bronchospasm, and antihistamines for allergic symptoms 5
• Corticosteroids (e.g., prednisone 40–60 mg daily) may be considered in severe cases with significant pulmonary involvement, though most cases resolve with drug withdrawal alone 5
• Monitor closely for 24–48 hours—symptoms typically improve rapidly after nitrofurantoin discontinuation, with complete resolution expected within days to weeks 5, 1, 2

If Treatment Failure or Resistant Infection Is Suspected (Persistent Urinary Symptoms Without Respiratory Findings)

Switch to an alternative antibiotic immediately while awaiting culture results:

• Fosfomycin 3 g single oral dose is an excellent choice for suspected resistant E. coli cystitis, with minimal cross-resistance to nitrofurantoin 3, 4, 6
• Fluoroquinolone (ciprofloxacin 500 mg twice daily for 7 days or levofloxacin 750 mg daily for 5 days) if local resistance is <10% and no recent fluoroquinolone exposure 3, 4, 6
• Avoid trimethoprim-sulfamethoxazole empirically given prior Bactrim failure and high community resistance rates 3, 6

If Pyelonephritis or Complicated Infection Is Suspected (Fever + Flank Pain or Systemic Signs)

Initiate empiric therapy for pyelonephritis immediately:

• Fluoroquinolone (ciprofloxacin 500 mg twice daily or levofloxacin 750 mg daily) for 7–10 days if local resistance permits 3, 4
• Parenteral therapy (ceftriaxone 1–2 g IV daily) if unable to tolerate oral intake, hemodynamically unstable, or concern for urosepsis 3, 4
• Obtain blood cultures before antibiotics if fever >38.3°C, rigors, hypotension, or suspected bacteremia 3, 4
• Consider imaging (renal ultrasound or CT) within 48–72 hours if symptoms do not improve to rule out obstruction, abscess, or nephrolithiasis 3, 4

Critical Pitfalls to Avoid

• Do not continue nitrofurantoin if fever and chills develop—acute drug toxicity can rapidly progress to respiratory failure or systemic inflammatory response syndrome 5, 1, 2
• Do not assume all fever during antibiotic therapy represents treatment failure—drug-induced fever and hypersensitivity reactions are common with nitrofurantoin, particularly on re-exposure 1, 2
• Do not delay culture collection—the initial non-clean-catch specimen is unreliable, and proper specimen collection is essential to identify resistant organisms 3, 4, 7
• Do not use nitrofurantoin for suspected pyelonephritis—it does not achieve adequate renal tissue concentrations and will fail in upper tract infections 3, 4
• Do not restart nitrofurantoin if drug toxicity is confirmed—re-challenge can precipitate severe, potentially life-threatening reactions 5, 1

Follow-Up and Long-Term Management

If nitrofurantoin toxicity is confirmed:

• Document allergy prominently in the medical record to prevent future exposure 5, 1
• Repeat chest radiograph in 4–6 weeks if pulmonary infiltrates were present to confirm complete resolution 5, 2
• Monitor liver function and complete blood count at 2–4 weeks to ensure resolution of transaminitis and thrombocytopenia 1

If recurrent UTI is confirmed:

• Obtain urine culture for each episode to document pathogens and resistance patterns 3, 4
• Consider prophylactic strategies after acute infection resolves: low-dose trimethoprim-sulfamethoxazole (if susceptible) or post-coital prophylaxis for sexually active women 8
• Evaluate for underlying risk factors: post-void residual volume, pelvic organ prolapse, atrophic vaginitis, or structural abnormalities 3, 4
• Avoid nitrofurantoin for future prophylaxis if drug toxicity occurred—alternative agents include trimethoprim-sulfamethoxazole or methenamine hippurate 8